BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 18182220)

  • 1. Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system.
    Schmaier AH
    Int Immunopharmacol; 2008 Feb; 8(2):161-5. PubMed ID: 18182220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel anti-thrombotic mechanisms mediated by Mas receptor as result of balanced activities between the kallikrein/kinin and the renin-angiotensin systems.
    Fang C; Schmaier AH
    Pharmacol Res; 2020 Oct; 160():105096. PubMed ID: 32712319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the plasma kallikrein/kinin system on endothelial cell membranes.
    Røjkjaer R; Schmaier AH
    Immunopharmacology; 1999 Sep; 43(2-3):109-14. PubMed ID: 10596841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the plasma kallikrein/kinin system on endothelial cells.
    Rojkjaer R; Schmaier AH
    Proc Assoc Am Physicians; 1999; 111(3):220-7. PubMed ID: 10354362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities.
    Schmaier AH
    J Thromb Haemost; 2016 Jan; 14(1):28-39. PubMed ID: 26565070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologic activities of the contact activation system.
    Schmaier AH
    Thromb Res; 2014 May; 133 Suppl 1(0 1):S41-4. PubMed ID: 24759141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assembly and activation of the plasma kallikrein/kinin system: a new interpretation.
    Shariat-Madar Z; Mahdi F; Schmaier AH
    Int Immunopharmacol; 2002 Dec; 2(13-14):1841-9. PubMed ID: 12489798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The plasma kallikrein-kinin system: its evolution from contact activation.
    Schmaier AH; McCrae KR
    J Thromb Haemost; 2007 Dec; 5(12):2323-9. PubMed ID: 17883591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma kallikrein/kinin system: a revised hypothesis for its activation and its physiologic contributions.
    Schmaier AH
    Curr Opin Hematol; 2000 Sep; 7(5):261-5. PubMed ID: 10961574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of plasma kallikrein-kinin system inhibitors from salivary glands of the blood-sucking insect Triatoma infestans.
    Isawa H; Orito Y; Jingushi N; Iwanaga S; Morita A; Chinzei Y; Yuda M
    FEBS J; 2007 Aug; 274(16):4271-86. PubMed ID: 17645545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelets promote coagulation factor XII-mediated proteolytic cascade systems in plasma.
    Johne J; Blume C; Benz PM; Pozgajová M; Ullrich M; Schuh K; Nieswandt B; Walter U; Renné T
    Biol Chem; 2006 Feb; 387(2):173-8. PubMed ID: 16497149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophils engage the kallikrein-kinin system to open up the endothelial barrier in acute inflammation.
    Kenne E; Rasmuson J; Renné T; Vieira ML; Müller-Esterl W; Herwald H; Lindbom L
    FASEB J; 2019 Feb; 33(2):2599-2609. PubMed ID: 30281335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel roles for factor XII-driven plasma contact activation system.
    Müller F; Renné T
    Curr Opin Hematol; 2008 Sep; 15(5):516-21. PubMed ID: 18695377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G Protein-Coupled Kinin Receptors and Immunity Against Pathogens.
    Scharfstein J; Ramos PIP; Barral-Netto M
    Adv Immunol; 2017; 136():29-84. PubMed ID: 28950949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF; Silver LD; Schapira M; Colman RW
    J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
    Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
    Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory mechanisms of the plasma contact system.
    Maas C; Renné T
    Thromb Res; 2012 May; 129 Suppl 2():S73-6. PubMed ID: 22398015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Factor XII and Kallikrein-Kinin System Combined with Neutrophil Extracellular Trap Formation in Diabetic Retinopathy.
    Song DY; Gu JY; Yoo HJ; Kim YI; Nam-Goong IS; Kim ES; Kim HK
    Exp Clin Endocrinol Diabetes; 2021 Aug; 129(8):560-565. PubMed ID: 31426112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of the N-terminal and C-terminal domains of haemaphysalin to inhibition of activation of plasma kallikrein-kinin system.
    Kato N; Okayama T; Isawa H; Yuda M; Chinzei Y; Iwanaga S
    J Biochem; 2005 Sep; 138(3):225-35. PubMed ID: 16169873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.